Anti-MYC monoclonal antibody
Pre-made anti-MYC monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to MYC/MYC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T36121-Ab-1/ GM-Tg-hg-T36121-Ab-2 | Anti-Human MYC monoclonal antibody | Human |
GM-Tg-rg-T36121-Ab-1/ GM-Tg-rg-T36121-Ab-2 | Anti-Rat MYC monoclonal antibody | Rat |
GM-Tg-mg-T36121-Ab-1/ GM-Tg-mg-T36121-Ab-2 | Anti-Mouse MYC monoclonal antibody | Mouse |
GM-Tg-cynog-T36121-Ab-1/ GM-Tg-cynog-T36121-Ab-2 | Anti-Cynomolgus/ Rhesus macaque MYC monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T36121-Ab-1/ GM-Tg-felg-T36121-Ab-2 | Anti-Feline MYC monoclonal antibody | Feline |
GM-Tg-cang-T36121-Ab-1/ GM-Tg-cang-T36121-Ab-2 | Anti-Canine MYC monoclonal antibody | Canine |
GM-Tg-bovg-T36121-Ab-1/ GM-Tg-bovg-T36121-Ab-2 | Anti-Bovine MYC monoclonal antibody | Bovine |
GM-Tg-equg-T36121-Ab-1/ GM-Tg-equg-T36121-Ab-2 | Anti-Equine MYC monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T36121-Ab-1/ GM-Tg-hg-T36121-Ab-2; GM-Tg-rg-T36121-Ab-1/ GM-Tg-rg-T36121-Ab-2; GM-Tg-mg-T36121-Ab-1/ GM-Tg-mg-T36121-Ab-2; GM-Tg-cynog-T36121-Ab-1/ GM-Tg-cynog-T36121-Ab-2; GM-Tg-felg-T36121-Ab-1/ GM-Tg-felg-T36121-Ab-2; GM-Tg-cang-T36121-Ab-1/ GM-Tg-cang-T36121-Ab-2; GM-Tg-bovg-T36121-Ab-1/ GM-Tg-bovg-T36121-Ab-2; GM-Tg-equg-T36121-Ab-1/ GM-Tg-equg-T36121-Ab-2 |
Products Name | Anti-MYC monoclonal antibody |
Format | mab |
Target Name | MYC |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-MYC monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
Target ID | GM-T36121 |
Target Name | MYC |
Gene ID | 4609,17869,24577,694626,403924,100379628,511077,100068097 |
Gene Symbol and Synonyms | bHLHe39,c-Myc,CMYC,mMyc,MRTL,MYC,Myc2,MYCC,Niard,Nird,RNCMYC,v-myc |
Uniprot Accession | P01106,P09416,B8XIA5,Q28350,P68271,Q2HJ27 |
Uniprot Entry Name | MYC_HUMAN,MYC_MACMU,MYC_RAT,MYC_FELCA,MYC_CANLF,MYC_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | Breast Cancer, Lung Cancer, Lung cancer |
Gene Ensembl | ENSG00000136997 |
Target Classification | N/A |
The target: MYC, gene name: MYC, also named as MRTLC, bHLHe39, c-Myc, MYC. This gene is a proto-oncogene and encodes a nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. The encoded protein forms a heterodimer with the related transcription factor MAX. This complex binds to the E box DNA consensus sequence and regulates the transcription of specific target genes. Amplification of this gene is frequently observed in numerous human cancers. Translocations involving this gene are associated with Burkitt lymphoma and multiple myeloma in human patients. There is evidence to show that translation initiates both from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site, resulting in the production of two isoforms with distinct N-termini. [provided by RefSeq, Aug 2017].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.